Abstract Microvascular hyperpermeability to plasma proteins via vascular endothelial growth factor (VEGF) with endothelial nitric oxide synthase (eNOS) induction may contribute to wound healing through matrix remodeling. However, vascular hyperpermeability is not examined in acute renal failure (ARF), a unique form of wound healing. Subcutaneous injection of gentamicin (400 mg/kg per day for 2 days in divided doses every 8 h) in rats increased serum creatinine levels and induced tubular damage, which peaked at day 6, after the last gentamicin injection. Ki67-positive regenerating proximal tubules (PTs) peaked in number at day 6 and almost covered the bare tubular basement membrane (TBM) by day 10. Staining of fibrinogen and plasma fibronectin began to increase in the peritubular regions as early as day 0, steadily increased in TBM and tubular lumen until day 6 and then decreased. Hyperpermeable peritubular capillaries were identified by extravasation of perfused-fluoresceinated dextran (both 70 kDa and 250 kDa) into peritubular regions as early as day 0 and prominently into TBM and tubular lumen at day 6.
Introduction
Microvascular hyperpermeability to plasma proteins (particularly fibrinogen and fibronectin) is a characteristic feature of normal wound healing and may contribute to wound healing through matrix remodeling [9, 12] . Extravasated fibrinogen clots to form a fibrin gel into which other plasma proteins, notably fibronectin, may be incorporated [45] . The interaction of fibronectin with fibrin and its incorporation into fibrin clots are thought to be important for the formation of a provisional matrix that promotes cell adhesion and migration [10, 22] . In this regard, the repair of tubular cells after acute renal failure (ARF) is a unique form of wound healing and a wellordered response to ischemic or toxic injury characterized by diverse cellular activities, which include inflammation, cell migration and matrix deposition or remodeling [2, 41, 42] . However, plasma protein extravasation in relation to the cellular recovery after ARF is poorly understood.
Since vascular endothelial growth factor (VEGF) is mitogenic, angiogenic and a potent mediator of vascular permeability [8, 14] , it is recognized as an important cytokine in wound healing [6, 31] . Nitric oxide (NO) production through NO synthase (NOS) by VEGF is known to play a critical role in VEGF-induced angiogenesis and vascular hyperpermeability [30, 46] , and endothelial NOS (eNOS) may play a predominant role in this process [15] . VEGF also acts as a maintenance factor on endothelial cells by stimulating anti-apoptotic actions [16] and as a chemotactic factor for monocytes. VEGF can function via two specific receptors, VEGF receptor-1 (Flt-1) and VEGF receptor-2 (Flk-1) [14, 39] , which are predominantly expressed on endothelial cells [36] .
In the kidney, VEGF is expressed in the visceral epithelial cells of glomeruli, proximal and distal convoluted tubules [29] and can induce nephrogenesis and vasculogenesis [43] . VEGF is also essential for endothelial-cell survival and repair during the course of glomerular disease models [26] , remnant kidney model [20] , obstructive nephropathy [32] and ischemic ARF model [19] . Peritubular capillaries surrounding proximal tubules (PTs) are one of the most fenestrated and permeable capillary networks in the body [33] . In this regard, Breier et al. [3] postulated that VEGF secreted from epithelial cells is involved in the maintenance of fenestrae in the endothelium. Thus, it is possible that an enhanced VEGF/ VEGF receptor pathway between PT and peritubular capillary endothelium could enhance the filtering function of the peritubular capillaries by structural modifications of the endothelium under cer-tain pathological conditions. The present study was designed to characterize hyperpermeability of peritubular capillaries to plasma proteins during gentamicin-induced ARF in rats. This model is a well-established toxic ARF model known to induce PT damage followed by recovery mainly in the renal cortex [23] . To better understand the underlying mechanisms responsible for hyperpermeability of peritubular capillaries, we assessed the expression levels of VEGF, VEGF receptors and eNOS as well as structural alterations in peritubular capillary endothelium and localization of infused dextran throughout the disease periods. In addition, we investigated the role of NO on vascular hyperpermeability during the recovery phase of this model by inhibiting NOS.
Materials and methods

Induction of gentamicin-induced ARF
A total of 79 male Wistar rats (200-250 g, SLC, Shizuoka) were used in the present study. Rats (n=44) were injected subcutaneously with 400 mg/kg body weight/day of gentamicin sulfate solution (Sigma-Aldrich Co., St. Louis, MO) for 2 days in divided doses (every 8 h) and were sacrificed before gentamicin administration and 8 h (day 0), day 2, day 6 and day 10 after the end of gentamicin administration. Five rats at each time point and five normal rats as controls were anesthetized with intraperitoneal pentobarbital sodium (30 mg/kg), and a blood sample was collected from the abdominal aorta. Then both kidneys were removed after flushing phosphate-buffered saline (PBS) for immunohistochemistry, immunofluorescence study and Western-blot analysis. Serum creatinine level was measured using the enzymatic method (Mizuho Med., Saga, Japan). For the study of microangiography and electron microscopy, six rats at each time point and six normal rats were used, respectively. As additional controls, eight rats were given a comparable amount of saline subcutaneously instead of gentamicin solution, and two rats at each time point were served for microangiography.
NO inhibition study
To investigate the role of NO on vascular hyperpermeability during the recovery phase of this model, NOS inhibitor N-nitro-l-arginine methyl ester (l-NAME, Sigma-Aldrich Co., St. Louis, MO) (100 mg/kg/day, s.c., n=8) or its vehicle saline (n=8) was administered to rats with gentamicin-induced ARF from day 3 to day 6, the last dose being given 1 h prior to sacrifice at day 6. Kidneys from the l-NAME group (n=5) and the vehicle group (n=5) were served for immunohistochemistry for Ki67 and a blood sample for measurement of serum creatinine level. Rats of l-NAME group (n=3) and vehicle group (n=3) were subjected to microangiography with fluorescein isothiocyanate (FITC)-labeled dextran (250 kDa).
Tissue processing
The harvested kidneys were bisected through the longitudinal axis, and some were cut into smaller pieces. They were fixed with 10% neutral-buffered formalin, 4% paraformaldehyde or methacarn solution and then were embedded in paraffin. Portions of renal cortex were snap frozen in cold n-hexane and stored at 70C for immunofluorescence studies and Western-blot analysis.
Histochemistry and immunohistochemistry
For histopathological examination, 4-m-thick paraffin sections were stained with periodic acid-Schiff (PAS). To detect VEGF, VEGF receptors-1 and -2, eNOS, rat endothelial cell antigen (RECA)-1, Ki67 and ED1 paraffin sections were first incubated with normal serum matched to the species for secondary antibodies. After incubation with the primary antibodies listed in Table 1 , sections were reacted with biotin-conjugated donkey anti-rabbit IgG (Chemicon International Inc., Temecula, CA) or donkey antimouse IgG (Chemicon) for 30 min at room temperature. Then, streptavidin-conjugated peroxidase (Nichirei, Tokyo, Japan) was added for 30 min. After washing in PBS, the reaction products were Table 1 Antibodies used to detect specific antigens in paraffin-embedded kidney sections. VEGF vascular endothelial growth factor, eNOS endothelial nitric oxide synthase, RECA rat endothelial cell antigen visualized using incubation with a diaminobenzidine detection kit (Nichirei).
Double immunostaining for RECA-1 and Ki67 was performed to evaluate the proliferative activity of peritubular capillary endothelium. After staining with RECA-1, sections were treated with microwave oven heating for 10 min in 0.01 M sodium citrate, pH 6.0, at 800 W and then were incubated with Ki67 as above and with donkey polyclonal biotinylated antibody against mouse IgG. Then NiCl 2 reagent (Vector Laboratories, Burlingame, CA) was added to obtain a dark blue staining color.
Histopathological control sections were treated as above except for omitting the primary antibodies or replacing the primary antibodies with normal mouse or rabbit IgG at equivalent concentrations.
Immunofluorescence studies
Immunofluorescence studies were performed on 4-m-thick cryostat sections fixed in cold acetone. Direct immunofluorescence was performed with FITC-labeled goat polyclonal antibody against human fibrinogen (ICN Pharmaceuticals Inc., Aurora, OH). Indirect immunofluorescence was performed with rabbit polyclonal antibody against rat plasma fibronectin (from rat plasma; Chemicon) and then followed by FITC-labeled donkey anti-rabbit IgG (Chemicon). The staining intensity was determined semi-quantitatively using a grading system of scales: , +, ++ and +++.
Microangiography
Microangiography was performed using the method of Pillebout et al. [35] with minor modifications. Briefly, 38 rats were anesthetized with ether, and the ventral aspect of both kidneys was exposed through a middle incision of the abdomen. Then rats were subjected to intrajugular injection of FITC-labeled dextran (size, 70 kDa or 250 kDa, Sigma Chemicals Co., St. Louis, MO) (100 g/g of body weight) in isotonic saline. Next, 60 s after injection, the kidneys were removed and immediately fixed overnight in 4% formalin. We chose the time point of sacrifice 60 s after injection since preliminary examinations showed that fluorescence decreased in renal vessels after 60 s, and only faint fluorescence was left in renal vessels in the cortex after 30 min. Other portions of the kidney were used for electron microscopic examination, while additional portions were paraffin embedded, and 4-m thick sections were cut, deparaffinized and observed with a fluorescent microscope (B50, Olympus, Tokyo).
Transmission electron microscopy
Small portions of 4% formalin-fixed renal tissues from FITC-250-kDa dextran-infused rats were further fixed in 2% glutaraldehyde in 0.1 M phosphate buffer (pH 7.4) for 2 h, postfixed in 1% osmium tetroxide resolved in the same buffer for 1 h and then embedded in Epon. Ultra-thin sections were counterstained with uranyl acetate and lead citrate and then examined under an electron microscope (JEM-1220, JEOL, Japan).
Western blot analysis of VEGF and eNOS
Immunoblotting was repeated at least three times with samples from a minimum of four animals for each time point and condition. Frozen kidney cortex was dissolved in radioimmunoprecipitation buffer (25 mM Tris-HCl, pH 7.4; 150 mM NaCl; 0.5% deoxychlolic acid; 0.5% Triton-X100 and 0.1% sodium dodecyl sulfate) at 4C containing 1 mM phenylmethylsulfonyl chloride, 1 g/ml aprotinin, 1 g/ml leupeptin and 1 g/ml pepstatin A. Equal amounts of proteins (40 g) were loaded for sodium dodecyl sulfate-polyacrylamide gel electrophoresis. After electrophoresis, those proteins were electroblotted onto nitrocellulose membranes.
The membranes were subsequently washed three times for 10 min each in Tris-buffered saline (TBS)-T (20 mM Tris-HCl, pH 7.6; 150 mM NaCl; and 0.1% Tween-20), incubated in TBS-T containing 2% skim milk for 1 h at room temperature to block non-specific binding and subsequently incubated with the primary antibody (VEGF-147 or eNOS) overnight at 4C. After the membranes were washed three times for 10 min each, they were incubated with horseradish peroxidase-conjugated donkey anti-rabbit antibody (OEM concept, Toms Rover, NJ) or sheep anti-mouse antibody (Amersham Life Science, Buckinghamshire, UK), diluted appropriately in TBS-T containing 2% skim milk for 1 h at room temperature. Antibodies bound to membrane-immobilized proteins were visualized using enhanced chemiluminescence (ECLTM, Amersham).
Morphometric analysis of PT cells and immunoreactive cells
To determine the number of PT cells, reflecting a balance of tubular cell death and tubular cell proliferation, we counted the number of nuclei in epithelial cells in cross-sections of the PTs in the cortex using PAS-stained sections and calculated the number of cells per tubular cross-section. The number of Ki67-positive PT cells and interstitial cells in the cortex was counted at 400 magnification. In addition, the number of ED1-positive cells in the interstitium was counted at 400 magnification. The number of immunoreactive cells in each rat represented the average number of 40 fields examined and the mean number before and at days 0, 2, 6 and 10, after induction of ARF was displayed in histograms. When double immunostaining of RECA-1 and Ki67 was performed, the total number of Ki67/RECA-1-double-positive cells among RECA-1-positive cells was counted in 40 randomly selected fields of the cortex at 400 magnification before and at day 2 and day 6 after induction of ARF, and the mean percentage of RECA-1/Ki67-positive cells was calculated at each time point.
Statistical analysis
Data are expressed as mean€SD. Differences between data sets were determined by one-way analysis of variance followed by Fisher's ttest. Comparison between values for l-NAME group and vehicle group was performed using paired t-test. A P level <0.05 was accepted as statistically significant. All statistical analyses were performed using Statview (Abacus Concept, Inc., Berkeley, CA).
Results
Gentamicin-induced ARF
Serum creatinine increased significantly as early as day 2 after the end of gentamicin administration (P<0.001 versus level before induction of ARF) and reached a peak value at day 6 (P<0.001 versus level before induction of ARF), then decreased afterward (Fig. 1) . Damage of the PTs in the cortex was detected as early as day 0, showing vacuolization, abnormal accumulation of PAS-positive inclusions. Furthermore, frank necrosis of PTs could be found at day 2 and day 6 as reported previously by others [20] , and denuded tubular basement membrane (TBM) was most prominent at day 6 ( Fig. 2A, B, C) . However, regenerating PTs were found at day 6, which were characterized as flat elongated cells with basophilic cytoplasm and dilated lumen (Fig. 2C ). These cells almost covered the entire bare TBM by day 10, when PTs became taller with brush-border (Fig. 2D) . The density of PT cells in the cortex decreased significantly as early as day 0 and progressively decreased by day 6, then increased over the baseline level at day 10 ( Fig. 3) .
Immunohistochemistry
Immunoreactive VEGF-147 was detected in the cytoplasm of the distal tubules and glomerular epithelial cells and weakly in the cytoplasm and brush-border of PTs in untreated kidneys (Fig. 4A ). After induction of ARF, staining of VEGF-147 in PTs was increased as a granular pattern in the cytoplasm as early as day 0 (Fig. 4B, C) . In addition to the cytoplasmic staining, staining of VEGF-147 was also found in the apical side of regenerating PTs at day 6 (Fig. 4D) . By day 10, staining pattern of VEGF-147 almost returned to the level seen in untreated kidneys (Fig. 4E) . VEGF-147 staining along the peritubular capillaries was not seen throughout the experimental period (Fig. 4A , B, C, D, E). Immunoreactive VEGF Ab-5 showed a staining pattern similar to that of VEGF-147 (Fig. 4H, I , J). In untreated kidneys, immunoreactive VEGF receptors-1 (Flt-1) and -2 (Flk-1) were similarly identified in the peritubular capillaries and glomerular endothelium, in the cytoplasm of the distal tubules and in the brush-border of PTs ( Fig. 4K, P) . The staining intensity of the peritubular capillary endothelium did not change after induction of ARF (Fig. 4L, M, N , O, Q, R, S, T). However, newly expressed VEGF receptors-1 and -2 were found in the regenerating PTs at day 6 (Fig. 4S) , and the staining pattern was shifted to the apical side of the PT at day 10 ( Fig. 4T) .
When primary antibodies were replaced with normal IgGs of the corresponding animals, no significant staining was observed in both normal control (Fig. 4F ) and experimental sections (Fig. 4G) . Immunoreactive eNOS was found intensely in the glomerular endothelium and slightly in the peritubular capillary endothelium of untreated kidneys (Fig. 5A) . After induction of ARF, intense staining for eNOS in the glomerular endothelium was not changed; however, induction of ARF was associated with a marked increase in staining for eNOS in peritubular capillaries as early as day 0 and was persistently high until day 10 (Fig. 5B, C, D, E) . However, immunoreactive RECA-1 was identified in peritubular capillaries and glomerular endothelium in untreated kidneys (Fig. 5F ). After induction of ARF, the staining was slightly decreased segmentally in some capillary endothelium only at day 6 (Fig. 5G, H, I, J) .
The number of Ki67-positive regenerating PT cells was significantly increased at day 6 and then was markedly decreased (Fig. 5K, L and Fig. 6 ). The number of Ki67-positive interstitial cells was significantly increased at day 2 and reached a peak level at day 6 (Fig. 5K, L and Fig. 6 ).
Double immunostaining of RECA-1 and Ki67 showed that the majority of RECA-1-positive peritubular capillary endothelial cells were negative for Ki67 (Fig. 5M) . The mean percentage of RECA-1/Ki67-double-positive endothelial cells among RECA-1-positive endothelial cells was 0.58% in normal controls, 0.63% at day 2 and 0.98% at day 6, indicating a low proliferative activity of RECA-1-positive peritubular capillary endothelial cells.
ED1-positive monocytes/macrophages were found only occasionally in the interstitium in untreated kidneys (data not shown). The number of ED1-positive cells was significantly increased as early as day 2, reached a peak level at day 6 and then decreased (Fig. 5N, O and Fig. 7 ) at day 10, although it was still higher than the baseline.
Immunofluorescence findings
Immunoreactive fibrinogen in the normal kidneys was almost confined to small areas in the peritubular capil- (Fig. 8A) and increased in the peritubular regions as early as day 0 (Fig. 8B) . Deposition of fibrinogen was identified in TBM and the tubular lumen at day 2 ( Fig. 8C) , reached a peak level at day 6 ( Fig. 8D ) and then markedly decreased (Fig. 8E) . Immunostaining pattern of plasma fibronectin was similar to that of fibrinogen (Fig. 8F, G, H, I, J) ; however, staining of the TBM was already identified at day 0 (Fig. 8G) . Table 2 summarizes the immunofluorescence findings.
Microangiography
In the normal kidneys, we observed fluorescence of infused-FITC-labeled dextran (both 70 kDa and 250 kDa) in peritubular vessels (Fig. 9A, F) and prominently in glomerular capillaries (not shown) in the renal cortex. After induction of ARF, such fluorescence increased in the peritubular regions and TBM as early as day 0 (Fig. 9B, G) and in the tubular lumen at days 2-6 ( Fig. 9C, D, H, I ). Extravasation of dextran reached peak levels at day 6 (Fig. 9D, I ) and then markedly decreased at day 10 ( Fig. 9E, J) . Only weak fluorescence was found in some Bowman's spaces in 70-kDa-dextran-infused normal rats, but not in 250-kDa-dextran-infused normal rats; however, there was no evidence for increased fluorescence in Bowman's spaces after induction of ARF (not shown). Extravasation of both sizes of dextran was almost confined to the cortex throughout the course of ARF. The fluorescence findings of infused-FITC-labeled dextran (both 70 kDa and 250 kDa) in peritubular vessels and glomerular capillaries were similar in normal control rats and vehicle saline injected rats at days 0, 2, 6 and 10 (not shown). Table 2 provides a summary of these findings.
Ultrastructural findings of 250-kDa-dextran-infused kidneys
Electron microscopy showed almost intact peritubular capillary endothelial lining without detachment or desquamation during the experimental period (Fig. 10A, B,  C, D) . Although some parts of endothelial cytoplasm became hypertrophic or swollen as early as day 2, no apparent alteration of fenestrae was evident in the attenuated parts of the endothelium (Fig. 10B, C, D) . In normal kidneys, TBM and the basement membrane of the endothelium could be clearly distinguished. However, after induction of ARF, the basement membrane of the endothelium became obscure and somewhat thickened (Fig. 10B, C, D) and could not be clearly separated from TBM (Fig. 10D) , suggesting the accumulation of plasma proteins and/or extracellular matrices in the peritubular regions and TBM.
In normal control kidneys, 250-kDa dextran was confined to the capillary lumen (Fig. 10A) . At days 2-6, dextran was often found in clusters in the cytoplasm of endothelial cells, in peritubular regions and in TBM (Fig. 10B, C, D) , where regenerating PTs could be found (Fig. 10D) . At days 2-6, dextran could be also found in the tubular lumen, where PTs were severely damaged or disappeared (Fig. 10C) . The amount of extravasated dextran was markedly decreased at day 10 (not shown).
Western-blot analysis
VEGF-147 blots demonstrated that expected VEGF isoforms, VEGF164 and VEGF188, were identified by their molecular weight as~23 kDa and~30-31 kDa, respectively (Fig. 11A) . After induction of ARF, VEGF levels markedly increased and remained at high levels until day 10 (Fig. 11A) . eNOS blots demonstrated that the band of the expected size (~140 kDa) was minimal in normal control kidney and markedly increased after induction of ARF, but transiently reduced at day 2 (Fig. 11B) .
NO inhibition study
In l-NAME-treated rats, we observed reduced fluorescence of infused-FITC-labeled dextran (250 kDa) in the peritubular regions and TBM and in the tubular lumen compared with vehicle-treated rats at day 6 (Fig. 12A, B) , suggesting that inhibition of NO during the repair phase of this model resulted in decrease in vascular hyperpermeability. In l-NAME-treated rats (n=5), serum creatinine level was significantly increased at day 6 and the number of Ki67-positive regenerating PT cells (Fig. 12C, D) was significantly reduced compared with vehicle-treated rats at day 6 (n=5) (serum creatinine; 3.91€ 0.62 mg/dl in vehicle group, 5.39€1.09 mg/dl in l-NAME group, P<0.05, the number of Ki67-positive regenerating PT cells per field; 22.7€2.7 in vehicle group, 17.6€2.0 in l-NAME group, P<0.05), indicating that inhibition of NO is linked to the inhibition of regenerative repair.
Discussion
In the present study, induction of ARF resulted in extravasation and deposition of fibrinogen (molecular weight, 340 kDa) and plasma fibronectin (molecular weight, 220 kDa), which reached peak levels on day 6, coinciding with the peak number of Ki67-positive regenerating PT. The presence of hyperpermeable peritubular capillaries was confirmed by the extravasation of injected FITC-labeled dextran (both 70-kDa and 250-kDa dextran), and the injected dextran was also found in the TBM and tubular lumen mainly at days 2-6, indicating that circulating macromolecules of about 250 kDa molecular weight could leak through the peritubular capillaries into the peritubular regions and modify the TBM, on which PTs actively regenerated. It is also possible that some circulating macromolecules reach the tubular lumen via Fig. 8 Photomicrographs of immunofluorescence for fibrinogen (A-E) and plasma fibronectin (F-J) in the renal cortex of control rats [before induction of acute renal failure (ARF), A, F] and at days 0 (B, G), 2 (C, H), 6 (D, I) and 10 (E, J) after induction of ARF. Immunofluorescence of fibrinogen and plasma fibronectin in the normal kidneys was almost confined to the small areas in the peritubular capillaries in the cortex (A, F), but increased in the peritubular regions as early as day 0 (B, G), and found in tubular basement membrane (TBM) and the tubular lumen at days 2-6 (C, D, H, I). However, TBM staining pattern of plasma fibronectin was already found at day 0 (G). These staining patterns reached peak levels at day 6 (D, I), then decreased at day 10 (E, J). Original magnification, 400 (A-J) damaged and/or desquamated PTs in our model, as suggested in the post-ischemic rat kidney by Zuk et al. [47] . In wound healing, extravasated fibrinogen clots to form a fibrin gel into which other plasma proteins may be incorporated [45] . Fibrin is thought to be an essential component of the provisional matrix that supports cellcell and cell-matrix interactions occurring during tissue remodeling and promotes the migration and proliferation of inflammatory cells, endothelial cells and interstitial cells participating in tissue repair [7, 10, 22] . The interaction of fibronectin with fibrin and its incorporation into fibrin clots are also important processes that promote cell adhesion and migration during wound healing [10, 22] . Fibrin(ogen) may provide a reservoir for cytokines and growth factors and has been shown to bind with high affinity to several angiogenic growth factors, including fibroblast growth factor-2 and VEGF [37, 38] . Therefore, it is likely that extravasated plasma fibrinogen and fibronectin acting as the provisional matrix play a role in tubular recovery after gentamicin-induced ARF.
The expression levels of VEGF and its receptor are closely regulated during vasculogenesis and angiogenesis, including wound healing [6, 28] . Capillary hyperperme- Fig. 9 Fluorescein isothiocyanate-labeled-70 kDa (A-E) and 250-kDa (F-J) dextran microangiography of renal cortex in rats before induction of acute renal failure (ARF) (A, F) and at days 0 (B, G), 2 (C, H), 6 (D, I) and 10 (E, J) after induction of ARF. In normal rats, fluorescence was found in peritubular vessels (A, F). After induction of ARF, fluorescence was increasingly found in peritubular regions and tubular basement membrane as early as day 0 (B, G), and in the tubular lumen at days 2-6 (C, D, H, I). Extravasation of both types of dextran reached peak levels at day 6 (D, I), then markedly decreased at day 10 (E, J). Original magnification, 400 (A-J) ability is also known to occur during wound healing [9, 12] , and VEGF appears to be involved, as evidenced by the overexpression of its receptor in the endothelium of regenerating vessels [27, 34] . Our results revealed upregulation of VEGF-147 protein in the cortex and increased immunoreactive VEGF-147 and VEGF Ab-5 in the damaged and regenerating PTs. Although immunoreactive VEGF receptors (Flt-1) and -2 (Flk-1) were not increased in peritubular capillaries, it is possible that increased VEGF released from the PTs can play a role in enhanced permeability via the VEGF/VEGF receptor system in this model. However, active proliferation of peritubular capillary endothelial cells was not found based on the findings of double immunostaining of RECA-1 and Ki67, suggesting vasculogenesis or angiogenesis may not be necessary for cellular recovery after ARF.
We also found that eNOS protein was markedly upregulated in the peritubular endothelium after induction of ARF. VEGF can induce the expression of eNOS and inducible NOS (iNOS) in vascular endothelial cells in vitro [17, 24] and promotes NO production. Murohara et al. [30] reported that NO and prostacyclin were produced by the interaction of VEGF with its VEGF receptor-2 as mediators of VEGF-induced vascular permeability. Furthermore, it is reported that inhibition of in vivo NO production results in reduced angiogenesis and vascular permeability induced by VEGF [30, 46] and that eNOS plays a predominant role in VEGF-induced angiogenesis and vascular permeability [15] . The data presented in this Fig. 10 Electron micrographs of renal cortex after 250-kDa dextran infusion. Localization of dextran particles (arrowheads) was confined to the peritubular capillary lumen in the normal control (A). At day 2, dextran particles were found in the peritubular regions and tubular basement membrane (TBM) (B). At day 6, dextran particles were found in the tubular lumen (C) and in the TBM, on which a proximal tubules (PT) cell regenerated (D). Note that the basement membrane of the endothelium became obscure at days 2 (B) and 7 (C, D). End peritubular capillary endothelium, bm basement membrane of the peritubular capillary endothelium, Asterisk hypertrophic or swollen endothelium. Bars 0.5 m study demonstrated that the NOS inhibitor l-NAME decreased hyperpermeability of peritubular capillaries during the recovery phase, suggesting that NO is an important mediator of vascular hyperpermeability in this model. However, it is not known whether this is a direct effect of NO on endothelial cells or whether NO merely decreases renal blood flow, although it is unlikely that NO-mediated vascular hyperpermeability is dependent on increase in blood flow. Thus, our findings that upregulation of VEGF in the PTs and of eNOS in the peritubular endothelial cells might suggest that NO, which may be produced through eNOS by VEGF, plays a role in VEGFinduced peritubular hyperpermeability. eNOS can be positively or negatively regulated by several factors, such as protein-protein interactions and covalent modifications [1] . In this study, immunoreactive eNOS showed intense staining in both the glomerular endothelium and the peritubular capillary endothelium after induction of ARF; however, eNOS blots demonstrated transient reduction of increased eNOS at day 2. It is reported that increased reactive oxygen species (ROS) generation plays a role in the NO-mediated inhibition of eNOS in endothelial cells [4, 5] . Thus, it might be possible that ROS generated by PT cells and mesangial cells during the injury phase of this model could inhibit eNOS production at day 2, as ROS are considered to be important mediators of gentamicin-induced nephrotoxicity [11, 25] .
l-NAME treatment in this model inhibited the regenerative repair of PT as judged by Ki67-positive PT cells and aggravated renal dysfunction as judged by serum creatinine level. We postulate that decreased peritubular hyperpermeability affected, at least in part, the morphological and functional recovery from gentamicin-induced ARF. However, l-NAME is a non-selective NOS inhibitor [21] ; thus, it is difficult to assess the results because different types of NOS may differently affect cell viability and function [1] . Moreover, it is also possible that inhibition of PT regeneration after l-NAME treatment in this model is secondarily caused by disturbance of NO-dependent regulation of renal hemodynamics and glomerular function as previously reported in gentamicininduced ARF [44] .
Due to the persistent expression of VEGF by epithelial cells adjacent to fenestrated endothelium, it has been Fig. 11 Western blots of protein from the renal cortex incubated with antibodies for vascular endothelial growth factor (VEGF)-147 (A) and endothelial nitric oxide synthase (B). VEGF-147 blots (A) showed weak bands of~23 kDa (lower arrowhead) and~30-31 kDa (upper arrowhead) in normal control, and the bands became stronger after induction of acute renal failure (ARF) (at days 0, 2, 6 and 10 days). On the other hand, eNOS blots (B) showed bands of 140 kDa (arrowhead) only after induction of ARF. C Normal control Fig. 12 Fluorescein isothiocyanate-labeled-250-kDa dextran microangiography (A, B) and photomicrographs of immunostaining for Ki67 (C, D) in vehicle-treated (A, C) and l-NAME-treated (B, D) rats at day 6 after induction of ARF. G glomerulus. Arrows Ki67-positive proximal tubule cells hypothesized that VEGF is involved in the maintenance of fenestrae in the endothelium [3] . While the peritubular capillary endothelium is fenestrated in normal kidneys, plasma proteins do not leak freely into the interstitial regions. The relative contribution of pathways of plasma protein extravasation through fenestrated endothelial layer is difficult to assess, since leakage of tracer macromolecules through these fenestrae cannot be excluded, even if other pathways, such as open intercellular junctions and transcellular pores, [3] do exist. In the present study, however, infused 250-kDa dextran could be found in the cytoplasm of peritubular endothelial cells as well as in the abluminal side of the adjacent endothelium after induction of ARF, suggesting the existence of transcellular pathway. However, due to technical limitations of tissue fixation, the resolution was not sufficient to evaluate whether dextran in the cytoplasm was extravasated by the way of vesiculovacuolar organelles [13] in this study. However, our results showed a significant infiltration of ED1-positive macrophages into the peritubular regions from day 2 to day 10. Yet, plasma protein extravasation was found as early as day 0, and the gap formation of peritubular capillary endothelium could not be observed in the cortex.
VEGF is also reported to act as a maintenance factor on endothelial cells through stimulation of anti-apoptotic pathways [16] , and this function may be implicated in other renal disease models [18, 40] . Induction of ARF in our experimental model resulted in hypertrophy or swelling of the peritubular capillary endothelium and slight reduction in constitutive molecule of rat endothelium, RECA-1, at day 6, suggestive of sublethal endothelial damage. Therefore, VEGF might also play a protective role for peritubular endothelial cells. The exact role of VEGF in the present model remains to be clarified.
In conclusion, our data suggested that plasma protein extravasation occurred, leading to matrix remodeling, such as the process of wound healing during the tubular repair in gentamicin-induced ARF. VEGF/VEGF receptor system with eNOS induction might be responsible for this process.
